Recent Patents on Inflammation & Allergy Drug Discovery
Title:Patent Selections
Volume: 6 Issue: 2
Author(s): Bentham Science Publishers
Affiliation:
Export Options
About this article
Cite this article as:
Bentham Science Publishers , Patent Selections, Recent Patents on Inflammation & Allergy Drug Discovery 2012; 6 (2) . https://dx.doi.org/10.2174/187221312800166868
DOI https://dx.doi.org/10.2174/187221312800166868 |
Print ISSN 1872-213X |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-2710 |
11
Related Articles
-
An update on Anti-inflammatory Compounds: A Review
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Transient Receptor Potential Vanilloid 1 Channel Modulation: A Novel Approach to Pain Therapy
Current Bioactive Compounds Delivery Methods of Camptothecin and Its Hydrosoluble Analogue Irinotecan for Treatment of Colorectal Cancer
Current Drug Delivery Feasibility and Prospects for Anti-Inflammatory Antibodies in the Treatment and Disease Management of Influenza
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Meet Our Editorial Board Member:
Current Drug Targets Biomarkers for Colorectal Cancer: Identification Through Proteomics
Current Proteomics Chemopreventive Properties of Tolfenamic Acid: A Mechanistic Review
Current Medicinal Chemistry Biomarker Metabolite Signatures Pave the Way for Electronic-nose Applications in Early Clinical Disease Diagnoses
Current Metabolomics The Ayurvedic Bhasma: The Ancient Science of Nanomedicine
Recent Patents on Nanomedicine The Interaction of Dietary Fibres with the Colon
Current Nutrition & Food Science Nanoemulsions: A Better Approach for Antidiabetic Drug Delivery
Current Diabetes Reviews Combination of Phytosterols and Omega-3 Fatty Acids: A Potential Strategy to Promote Cardiovascular Health
Current Medicinal Chemistry - Cardiovascular & Hematological Agents Arginine Deprivation as a Targeted Therapy for Cancer
Current Pharmaceutical Design Cardiovascular Biology of Interleukin-6
Current Pharmaceutical Design Reactive Oxygen Species, Cancer and Anti-Cancer Therapies
Current Chemical Biology The GABAergic System and the Gastrointestinal Physiopathology
Current Pharmaceutical Design Intraperitoneal Chemotherapy as First-Line Treatment in the Management of Epithelial Ovarian Cancer
Mini-Reviews in Medicinal Chemistry Anti-TNF Antibodies in Inflammatory Bowel Disease: Do We Finally Know How it Works?
Current Drug Targets Gut Permeability and Microbiota in Parkinson’s Disease: Role of Depression, Tryptophan Catabolites, Oxidative and Nitrosative Stress and Melatonergic Pathways
Current Pharmaceutical Design The Role of Bevacizumab in Advanced Epithelial Ovarian Cancer
Current Pharmaceutical Design